These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1285414)

  • 21. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
    Sagan S; Chassaing G; Pradier L; Lavielle S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis and biological activity of substance P analogs].
    Liu SY; Zhong MN; Dong YX; Li YL; Yuan XM
    Yao Xue Xue Bao; 1997 Dec; 32(12):938-42. PubMed ID: 11596194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
    Fardin V; Garret C
    Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly potent substance P antagonists substituted with beta-phenyl- or beta-benzyl-proline at position 10.
    Lavielle S; Brunissen A; Carruette A; Garret C; Chassaing G
    Eur J Pharmacol; 1994 Jun; 258(3):273-6. PubMed ID: 7522179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
    Hall JM; Mitchell D; Morton IK
    Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder.
    Torrens Y; Saffroy M; Glowinski J; Beaujouan JC
    Neuropeptides; 1997 Jun; 31(3):243-51. PubMed ID: 9243521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 'septide-sensitive' tachykinin receptor: still an enigma.
    Glowinski J
    Trends Pharmacol Sci; 1995 Nov; 16(11):365-7. PubMed ID: 8578604
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
    Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
    J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity.
    Haro I; Busquets MA; Torres JL; Valencia G; Garcia-Anton JM; Reig F
    J Pharm Sci; 1990 Jan; 79(1):74-6. PubMed ID: 1690289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.
    Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Chassaing G; Lavielle S; Besseyre J; Garret C; Carruette A; Glowinski J
    J Neurochem; 1991 Mar; 56(3):879-89. PubMed ID: 1704425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.
    Laufer R; Gilon C; Chorev M; Selinger Z
    J Med Chem; 1986 Jul; 29(7):1284-8. PubMed ID: 2433445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3H-substance P binding to guinea-pig ileum longitudinal smooth muscle membranes.
    Watson SP; Iversen LL
    Regul Pept; 1984 Jul; 8(4):273-81. PubMed ID: 6208574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis.
    Hastrup H; Schwartz TW
    FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat.
    Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
    Biochem Biophys Res Commun; 1993 Feb; 191(1):180-7. PubMed ID: 7680554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice.
    Ravard S; Betschart J; Fardin V; Flamand O; Blanchard JC
    Brain Res; 1994 Jul; 651(1-2):199-208. PubMed ID: 7522932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A "septide-sensitive" receptor is not involved in tachykinin-mediated secretory and inositol phosphate responses in rat parotid gland: are several transduction pathways involved after the stimulation of the NK1 receptor?
    Huleux C; Berthier A; Rossignol B; Dreux C
    J Neurochem; 1998 Feb; 70(2):858-64. PubMed ID: 9453583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of tachykinin-stimulated inositol phospholipid hydrolysis in peripheral tissues.
    Suman-Chauhan N; Guard S; Williams BJ; Watling KJ
    Br J Pharmacol; 1990 Dec; 101(4):1001-5. PubMed ID: 1707702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.